
About Hemex Health
Hemex Health is a Healthcare company based in Portland (United States) founded in 2016. Platform providing care devices for the detection of tropical diseases. Hemex Health has raised $6.24 million across 16 funding rounds from investors including NIH, The Indus Entrepreneurs and CTIP. The company has 1 employees. Its chief executive, as recorded, is Patti White. Its Indian entity Hemexdx Private Limited reported revenue of βΉ30.36 Cr. Its focus areas include Life Sciences, Hematology, In Vitro Diagnostics Tests and Hemoglobinopathies. Its competitors include BioMedomics, Silver Lake Research Corporation and Halcyon Biomedical; 1 of its 3 listed competitors has raised funding.
Company details
Hemex Health was founded in 2016 in Portland, United States, within the health technology sector. Medical devices for diagnosing tropical diseases are developed through the platform. Two products are currently under development: a magneto-optical device used for rapid detection of all malaria species and HemeChip, a miniaturized form of cellulose acetate electrophoresis applied in sickle cell anemia diagnosis. Operations focus on point-of-care solutions for global health challenges.
- Headquarters Portland, United States
- Employees 1
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website hemexhealth.com
- Legal Name Hemexdx Private Limited
- Date of Incorporation 15 May, 2018
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹30.36 Cr
FY 2025 · +16% YoY
- Indian entity net loss-₹5.45 Cr
FY 2025 · -18% margin
- Indian entity EBITDA-₹5.35 Cr
FY 2025 · -18% margin
- Total Equity Funding$6.24M (USD)
in 16 rounds
- Latest Funding Round$332.12K (USD), Grant
Sep 2024
- InvestorsNIH
& 10 more
- Employee Count1
Associated legal entities of Hemex Health
Hemex Health operates through Hemexdx Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Hemexdx Private Limited CIN U33309MH2018PTC377201 | Active | 15 May 2018 | Thane, Maharashtra | ₹30.4 Cr | 36 | 4 | View details |
Funding Insights of Hemex Health
Hemex Health has successfully raised a total of $6.24M across 16 strategic funding rounds. The most recent funding activity was a Grant round of $332.12 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.24M
- Total Rounds 16
- Last Round Grant β $332,122
- First Round $50,000
(Oct 2016)
- Investors Count 11
Latest 10 of 16 funding rounds of Hemex Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $332,122 | Grant | β | β | |
| Jan 2024 | $295,920 | Grant | β | β | |
| Mar 2023 | $3M | Grant | β | β | |
| Mar 2022 | Grant | β | β | ||
| Apr 2021 | $256,580 | Grant | β | β | |
| Oct 2020 | $100,000 | Grant | β | β | |
| Aug 2020 | $1.67M | Grant | β | β | |
| Apr 2020 | $225,000 | Grant | β | β | |
| Sep 2018 | $3.72M | Grant | β | β | |
| Aug 2018 | $1.96M | Grant | β | β |
11 investors in total: 11 institutional.
Investors in Hemex Health
Hemex Health has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, The Indus Entrepreneurs and CTIP.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of angel network firm | 1992 | tie.org | Sunnyvale, United States | |
| pipelineangels.com | ||||
| k4northwest.com | ||||
| allianceofangels.com | ||||
Venture capital fund focused on underserved entrepreneurs is provided. | elevate.vc | Hillsboro, United States | ||
An angel investment conference is organized in Bend, Oregon. | bendvc.com | Bend, United States | ||
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
| westcoastctip.org | ||||
| willametteconference.com | ||||
| clinicbyclevelandclinic.com |
Investor details for Hemex Health
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Hemexdx Private Limited (Hemex Health)
Hemexdx Private Limited is the primary company behind Hemex Health. The board of Hemexdx Private Limited currently have 4 directors; the longest-serving is Amrish Kantilal Mehta, appointed in 2018. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Amrish Kantilal Mehta DIN 07463167 | Director | 30 May 2018 | 8 yrs 5 mo | Hemexdx Private Limited |
| Patricia White Seminario DIN 08146127 | Director | 30 May 2018 | 8 yrs 5 mo | Hemexdx Private Limited |
| Prashant Pramodrao Khadke DIN 02622405 | Managing Director | 09 Jun 2023 | 3 yrs 5 mo | Hemexdx Private Limited |
| Suhas Suresh Tamras DIN 11212131 | Nominee Director | 13 Aug 2025 | 1 yr 3 mo | Hemexdx Private Limited |
People of Hemex Health
23 people are tracked at Hemex Health (16 in leadership, 7 in team); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Patti White | CEO | Leadership |
Peter Galen | Chief Innovation Officer | Leadership |
David Bell | Chief Medical Officer | Leadership |
Mohan Uttarwar | Founding Director, HemexDx | Leadership |
Poornima Kumar | Managing Director, Hemexdx | Leadership |
Alireza Nasiri Avanaki | Chief Scientist, Algorithms | Leadership |
Brian Grimberg | Chief Scientist, Malaria | Leadership |
| VP, Commercial Operations, Hemexdx | Leadership | |
Daren Bledsoe | VP, Engineering | Leadership |
Gerrit J. van Roekel | VP, Business Development | Leadership |
Sulatha Dwarakanath | VP Of Assay Product Development | Leadership |
Priya Thota M.D. (Healthcare Mgmt) | Director Of Clinical Research And Operations | Leadership |
J. Daren Bledsoe | Senior Vice President Of Engineering And Operations | Leadership |
Sagar Parab | Deputy General Manager | Leadership |
Tyler Witte | Director Of Research And Development | Leadership |
Umut Gurkan | Chief Scientist, Microfabrication | Leadership |
Anurag Sharma | Growth Manager | Team |
Yiyang Fei | Software Engineer | Team |
Joel Levenson | Industrial Design/ Prototype Engineer | Team |
Shabbir Najmi | Manager- Field Application & Support | Team |
3 more people are available in the full profile.
Complete people profiles for Hemex Health
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Hemex Health
Figures of Hemexdx Private Limited, the primary company behind Hemex Health, for FY 2025. Revenue was ₹30.36 Cr (+16% year on year). Net loss was -₹5.45 Cr (-18% margin). EBITDA was -₹5.35 Cr (-18% margin). Revenue has grown at a compounded annual rate of +52% over three years.
- ₹30.36 CrRevenue · FY 2025 · +16% YoY
- -₹5.45 CrNet loss · -18% margin
- -₹5.35 CrEBITDA · -18% margin
- ₹2 LakhPaid-up capital
- 36Employees (provident fund records)
- +52%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Hemexdx Private Limited are on its company page.
Detailed financial statements for Hemex Health
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Hemex Health
3 dated milestones of Hemex Health across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Hemex Health is founded.
- Funding First funding round of $50K.
- Funding Latest funding round, Grant, of $332K.
Competitors of Hemex Health
Hemex Health has 3 listed competitors in our database, 1 of them funded. They include BioMedomics, Silver Lake Research Corporation and Halcyon Biomedical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biomedomics.com | 2006 | Durham, United States | $1.5M | 14 | Point-of-care diagnostic systems for blood-based disorders are developed. | |
| silverlakeresearch.com | 1993 | United States | 32 | Custom antibodies and diagnostics are developed for various applications. | ||
| halcyonbiomedical.com | 2013 | Friendswood, United States | Diagnostic solutions for hematological disorders |
Detailed competitors of Hemex Health
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Hemex Health
The website of Hemex Health (hemexhealth.com) receives about 2.1K visits a month.
- Monthly visits2.1K
▼ 8.4% vs previous month
Top companies in Hematology
3 companies that operate in the same segment as Hemex Health (Hematology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 300 M | 384 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hemex Health
Complete news archive for Hemex Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemex Health
Hemex Health was founded in 2016.
Hemex Health is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
Patti White is the CEO of Hemex Health, as recorded in our data.
Hemex Health is a funded company, having raised a total of $6.24M across 16 funding rounds to date. The company's 1st funding round was a Grant of $1.96M, raised on Oct 2016.
Hemex Health has 1 employees.
The primary company behind Hemex Health, Hemexdx Private Limited, reported revenue of βΉ30.36 Cr for FY 2025, up 16% year on year.
Hemex Health was founded in 2016 in Portland, United States, within the health technology sector. Medical devices for diagnosing tropical diseases are developed through the platform. Two products are currently under development: a magneto-optical device used for rapid detection of all malaria species and HemeChip, a miniaturized form of cellulose acetate electrophoresis applied in sickle cell anemia diagnosis. Operations focus on point-of-care solutions for global health challenges.
Hemex Health's top competitors include Silver Lake Research Corporation, BioMedomics and Halcyon Biomedical.
Hemex Health has 11 investors. Key investors include NIH, The Indus Entrepreneurs, CTIP, Pipeline Angels, and Keiretsu Forum Seattle.
Hemex Health operates through Hemexdx Private Limited.
The legal entities of Hemex Health currently have 4 directors, including Amrish Kantilal Mehta, Patricia White Seminario, Suhas Suresh Tamras and others.
